Entering text into the input field will update the search result below

Proximus: A Victim Of A Poor IPO Market, Immense Capex Burden

Jul. 02, 2023 1:36 AM ETProximus PLC (BGAOF), BGAOY

Summary

  • Proximus had put quite a lot of hope into Telesign, which made a value case for the company's compressed multiple, but the IPO failed.
  • We are beginning to see a pickup in IPO activity, but things are still highly uncertain, and capital markets remain wary of growth stories. No catalyst yet.
  • Additionally, the capex burden is a concern.
  • While Proximus trades cheaply, the dividend is not actually sustainable on business performance. We think that this in addition to the Belgian state involvement is the problem for the valuation.
  • While the dividend remains at risk, and with IPO markets still rather shut, the case for Proximus is difficult. Only on an IPO market recovery could the stock be revisited, and even then, capex is still an issue.
  • Looking for a helping hand in the market? Members of The Value Lab get exclusive ideas and guidance to navigate any climate. Learn More »
summer sales in Brussels, Belgium

Alexandros Michailidis/iStock Editorial via Getty Images

Proximus PLC (OTCPK:BGAOF) is Belgian's telco company. Like many others in Europe, it is undergoing massive capex to modernise its copper networks and bring fibre to the people. This capex is a massive overhang, and they are beholden to it not only for

If you thought our angle on this company was interesting, you may want to check out our idea room, The Value Lab. We focus on long-only value ideas of interest to us, where we try to find international mispriced equities and target a portfolio yield of about 4%. We've done really well for ourselves over the last 5 years, but it took getting our hands dirty in international markets. If you are a value-investor, serious about protecting your wealth, our gang could help broaden your horizons and give some inspiration. Give our no-strings-attached free trial a try to see if it's for you.

This article was written by

Leader of The Value Lab
A long-only voice with eclipsing growth through 2020 and 2022 bear markets.

Formerly Bocconi's Valkyrie Trading Society, seeks to provide a consistent and honest voice through this blog and our Marketplace Service, the Value Lab, with a focus on high conviction and obscure developed market ideas.

DISCLOSURE: All of our articles and communications, including on the Value Lab, are only opinions and should not be treated as investment advice. We are not investment advisors. Consult an investment professional and take care to do your own due diligence.

DISCLOSURE: Some of Valkyrie's former and/or current members also have contributed individually or through shared accounts on Seeking Alpha. Currently: Guney Kaya contributes on his own now, and members have contributed on Mare Evidence Lab.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

Comments

Disagree with this article? Submit your own. To report a factual error in this article, . Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.